News and Features
NovaVision VRT™ Vision Restoration Therapy™ has been covered in many news reports and has been the subject of many scientific studies. In addition, patient success stories shed light on this FDA-approved therapy. Learn more about the background of VRT by viewing the news and features below.
Vision Restoration Therapy News
Many newspapers, magazines, and TV news programs have featured VRT as a cutting-edge treatment for vision loss following stroke or traumatic brain injury. View VRT news stories.
VRT Success Stories
Those who have undergone VRT find that it improves their mobility, independence, confidence, and quality of life. Read their stories to learn more about this exciting treatment.
FDA Clearance — NovaVision, Inc.’s VRT Vision Restoration Therapy
On April 22, 2003, the U.S. Food and Drug Administration granted 510(k) clearance to NovaVision Vision Restoration Therapy. The therapy is intended for the diagnosis and treatment of vision loss caused by traumatic brain injury, stroke, inflammation, surgical removal of brain tumors, and brain surgery.
View document discussing FDA clearance of Vision Restoration Therapy.
Learn More about VRT
NovaVision Vision Restoration Therapy can treat a variety of vision defects common after stroke or traumatic brain injury, including hemianopia, quadrantanopia, scotoma, and diffuse field defect / low vision. To learn more about vision rehabilitation, please contact NovaVision™ by email or call NovaVision Patient Services toll-free at 1.866.414.0009.